Tamara Monesmith

Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma

Joshua Richter, Natalia Neparidze, Lin Zhang et al. · Blood · 2012 · 166 citations · Full text

Medicine, Immunology, Oncology +16

Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy

Jean‐Pierre Routy, Mohamed‐Rachid Boulassel, Bader Yassine‐Diab et al. · Clinical Immunology · 2009 · 120 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Monitoring T-cell responses in a phase II study of AGS-003, an autologous dendritic cell-based therapy in patients with newly diagnosed advanced stage renal cell carcinoma in combination with sunitinib.

Robert A. Figlin, Charles A. Nicolette, Alpesh Amin et al. · Journal of Clinical Oncology · 2011 · 21 citations

Medicine, Immunology, Oncology +17

Interim analysis of the phase 3 ADAPT trial evaluating rocapuldencel-T (AGS-003), an individualized immunotherapy for the treatment of newly-diagnosed patients with metastatic renal cell carcinoma (mRCC)

Robert A. Figlin, Charles A. Nicolette, Nizar M. Tannir et al. · Annals of Oncology · 2017 · 12 citations

Medicine, Immunology, Oncology +14

An improved RNA amplification procedure results in increased yield of autologous RNA transfected dendritic cell-based vaccine

Jason Harris, Tamara Monesmith, Alicia Ubben et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2005 · 10 citations

Life Sciences, Immunology, Vaccine Biotechnology +16